Daesang Corporation Overview
Daesang is South Korea's second-largest diversified food and ingredients manufacturer after CJ CheilJedang, with KRW 4.40 trillion of FY2025 revenue split roughly 69:31 between Food and Materials (2Q26 mix). Its consumer franchise rests on heritage brands: Miwon, Korea's first fermented seasoning (1956); Chungjungone in sauces and jang; and Jongga, the dominant Korean kimchi exporter with 56% of national kimchi exports in 1H26. The Materials arm is a scale producer of corn starch and starch sugars, the largest of four oligopolists, alongside MSG, nucleotides, lysine, specialty amino acids, allulose and microalgae proteins. Group margins are thin (3–4% operating) but stable, and cash generation funds a 4–5% dividend yield. The investment case was reset in 2025–26 by a record KRW 234.1bn KFTC fine for starch-sugar price-fixing, criminal indictment of the CEO, and a FY2025 net loss of KRW 303.1bn. The shares now trade at roughly 0.56x book.
What the company does
Daesang manufactures and sells processed foods and food and bio ingredients in Korea and internationally. Stoxray's profile states that bio-ingredient products are exported to roughly 80 countries under the Miwon brand. Daesang's own 2026 press materials describe it as headquartered in Korea with manufacturing subsidiaries in the United States, Poland, China, Indonesia and Vietnam (PRNewswire, 29 Sep 2026). The company reports two principal segments:
Food (식품) — about 69% of 2Q26 revenue
-
Branded consumer foods: jang (gochujang, doenjang, soy sauce), sauces and dressings, seasonings, kimchi and fresh foods, home meal replacement (HMR) and convenience foods, laver (gim), health-oriented and low-sugar lines.
-
B2B and food-service supply.
Materials (소재) — about 31% of 2Q26 revenue
-
Starch and starch sugars: glucose, high-fructose syrups, maltose syrup, oligosaccharides, alternative sugars, and wet-milling by-products such as gluten, germ and fibre.
-
Fermentation products: MSG, nucleotides, lysine, histidine and other amino acids, natural seasoning materials (NAMINO), microalgae proteins.
-
Allulose sold under the Sweevero brand.
Company's own description
In management's FY2025 results commentary (Dealsite, 29 Jan 2026), Daesang attributed growth to:
-
domestic health foods, sauces and fresh foods;
-
high-value bio products such as histidine;
-
global laver, sauces and convenience foods.
It attributed margin pressure to US reciprocal tariffs and weaker starch-sugar demand from alcohol and beverage customers.
Revenue model
The mix is overwhelmingly product sales: manufactured goods sold through retail (B2C), food-service and industrial (B2B) channels, plus exports. There is no material subscription, licensing or service revenue. A precise B2C/B2B split is not publicly disclosed in retrieved sources.
Value-chain position
| Stage | Daesang's role |
|---|---|
| Raw materials | Buyer of imported corn (starch milling), raw sugar and molasses or other fermentation feedstocks, cabbage and vegetables (kimchi), soybeans and chili (jang). Exposed to grain prices and FX. |
| Primary processing | Corn wet-milling and starch-sugar conversion (Gunsan, Korea's largest such plant per Jeonbuk Ilbo, 2006). Fermentation of amino acids and MSG. |
| Secondary processing | Branded foods, kimchi, HMR, sauces |
| Distribution | Korean retail (hypermarkets, convenience, online), food-service, overseas subsidiaries and distributors in the US, Europe and Asia |
| Customers | Consumers, restaurants and caterers, and food and beverage manufacturers. Brewers, dairy and noodle makers buy starch sugar; prosecutors named Seoul Milk, Korea Yakult, Nongshim, HiteJinro, OB Beer and POSCO as bid customers. Feed makers buy lysine; paper and steel makers buy industrial starch. |
Independent characterisation
Daesang is a dual-engine business:
-
A mature, low-growth domestic branded-food franchise with strong brand equity but intense competition and retailer bargaining power.
-
A commodity-cyclical ingredients business whose profits swing with corn costs, amino-acid pricing (notably lysine) and, as the 2026 cartel ruling showed, the competitive conduct of a concentrated domestic oligopoly.
The most credible growth vectors are overseas kimchi and K-sauces, and specialty ingredients (allulose, histidine, natural seasonings). The most material near-term issues are legal and regulatory rather than operational.
Strategy
Stated strategic themes (management statements, paraphrased)
2023 AGM (Lim Jung-bae): - Maximise profitability via value-chain efficiency: focus food on high-margin channels and optimise the portfolio; in materials, maximise cost reduction and manufacturing differentiation.
-
Secure growth engines: kimchi, sauces and laver globally; local businesses in the US, Southeast Asia and Europe; high-value new materials.
-
Pursue sustainable growth anchored in the core value of "respect" and ESG (Dealsite, 24 Mar 2023).
2024 New Year message: qualitative growth through business-structure upgrading and technology differentiation; talent (internal venture programme "we대한상상"); crisis management covering liquidity, safety and compliance, plus GHG and waste management (Dealsite, 2 Jan 2024).
FY2025 results (Jan 2026): - Prune non-core and low-efficiency categories; concentrate people on core and growth categories.
-
Scale natural seasoning materials and allulose; strengthen high-end amino-acid line-ups.
-
Focus globally on kimchi, gochujang and laver; strengthen B2B and localisation in the US, China and Japan.
-
Enter Russia, Canada, the Middle East and Latin America with K-food sauces and convenience foods (Dealsite, 29 Jan 2026).
2H26 plan (Aug 2026): - Expand high-value product groups; target new markets in broths and menu seasonings; strengthen the health-oriented portfolio.
-
Global food: localisation in kimchi, laver, sauces and convenience foods.
-
Materials: restructure toward high value-added; expand specialty items; diversify lysine supply regions; widen the alternative-sweetener portfolio; decarbonise manufacturing bases; improve energy competitiveness (Dealsite, 14 Aug 2026).
Initiative register (last 24 months)
| Initiative | Date | Detail | Status |
|---|---|---|---|
| Sweevero global roll-out | 2024 onward | Allulose sales in North America, Southeast Asia, Europe, South America | 9M25 overseas sales +300% YoY |
| LOWTAG low-sugar line | 2,025 | About 20 SKUs across jang, vinegar drinks and sauces using in-house allulose | Launched |
| Strategic supply chain / cost reduction | 2H25 | Announced after the 2Q25 margin miss | Ongoing; 2Q26 food margin improved |
| Jongga US expansion | 2025–26 | LA plant plus Lucky Foods; mainstream retail; Head in the Clouds LA 2025 | Ongoing |
| Category pruning | 2,026 | Exit non-core, low-efficiency categories | Announced Jan 2026 |
| New-market entry | 2,026 | Russia, Canada, Middle East, Latin America | Announced |
| Manufacturing decarbonisation | 2,026 | Decarbonise production bases; energy competitiveness | Announced Aug 2026; targets not disclosed |
| KFTC compliance | Jul 2026 onward | KFTC orders independent re-determination of starch-sugar prices to pre-cartel competitive levels | Mandatory; implementation not disclosed |
Medium-term financial targets and guidance
Not publicly disclosed. Daesang does not publish numerical guidance in retrieved sources.
Products & Services
Pricing is not publicly disclosed for any product line. "Launch / latest" years are given only where sourced.
Food segment
| Brand / line | Description | Target customer | Launch / latest | Notes |
|---|---|---|---|---|
| Miwon (미원) | Fermented MSG seasoning (consumer packs) | Households, food service | 1,956 | Korea's first fermented seasoning brand (KIS via Dealsite, 2021) |
| Chungjungone (청정원) | Master consumer brand: jang, sauces, dressings, seasonings, HMR, vinegar drinks, allulose | Households | Mid-1990s | Hosts LOWTAG and allulose B2C lines |
| Sunchang (순창) | Gochujang and traditional jang under Chungjungone | Households | Heritage | First LOWTAG low-sugar products launched here (Food Today) |
| Haetsal Damun (햇살담은) | Soy sauce line under Chungjungone | Households | Heritage | LOWTAG roll-out (Food Today) |
| LOWTAG | Low-sugar / low-calorie emblem across jang, vinegar drinks, sauces and dressings (e.g. low-sugar brown-rice gochujang, chogochujang, bibim-noodle sauce) | Health-conscious consumers | 2025 (about 20 SKUs targeted) | Uses in-house allulose |
| Chungjungone Allulose (cooking / syrup) | Two B2C allulose products with different viscosity and sweetness | Households, diabetics | Mid-2024 | Korea Diabetes Association MOU, 1 Jul 2024 (Insight) |
| Jongga (종가) | Kimchi: Original, Vegan, White, extra-spicy Silbi, Cucumber; sold in 90+ countries | Korean and global retail | Acquired c.2006; US-made varieties since 2022 | Exports USD 90m in 2025; USD 48m in 1H26, 56% of Korea's total (PRNewswire) |
| Laver / gim | Seasoned seaweed for domestic and export markets | Global retail | — | A named global core category (Dealsite, 2026) |
| Sauces and convenience foods (global) | K-sauces (gochujang-based), ready meals for overseas markets | Overseas mainstream retail | — | Named growth categories for new markets (Russia, Canada, Middle East, Latin America) |
| Broths and menu seasonings | Stock and menu-specific seasoning products | Households, food service | 2H26 focus | Named as new target markets (Dealsite, 14 Aug 2026) |
| Food B2B / food service | Ingredient and processed-food supply to restaurants and caterers (incl. legacy Bestco operations) | Restaurants, institutions | — | Low-margin accounts pruned after the Bestco merger (Hana, 2020) |
| Overseas local brands | Vietnam processed meats (Duc Viet), Indonesia consumer seasonings | Local consumers | — | — |
Materials segment
| Product line | Description / specifications | Target customer | Year | Notes |
|---|---|---|---|---|
| Corn starch | Native and modified starch from wet milling | Food, paper, steel, textile makers | Gunsan since 2002–06 | The four oligopolists hold 95.7% of Korean B2B starch (KFTC, 2026) |
| Starch sugars | Glucose, fructose (HFCS), maltose syrup (mul-yeot), oligosaccharides, alternative sugars | Beverage, dairy, confectionery, bakery, brewing | — | The four firms hold 86.4% of B2B starch sugar (KFTC). Subject of the 2026 cartel ruling. |
| By-products | Gluten, protein fibre, germ | Feed, oil and food processors | — | Separate KFTC by-product case pending (2026) |
| Sweevero allulose | Rare sugar; about 70% of sugar's sweetness at about 10% of the calories (company) | Global food and beverage manufacturers | Plant Jul 2023; brand Jan 2024 | Overseas sales up more than 300% YoY in 9M25 (Herald, 23 Nov 2025) |
| MSG (Miwon) | Fermented monosodium glutamate | Food processors, exporters | 1,956 | Exported to about 80 countries under Miwon (Stoxray) |
| Nucleotides | Flavour enhancers (IMP and GMP) | Food processors | — | — |
| Lysine | Feed-grade amino acid | Feed producers (EU, Asia) | — | Benefited from EU anti-dumping duties on Chinese lysine (2025). 2026 plan: supply-region diversification. |
| Histidine and high-end amino acids | Specialty amino acids | Pharma, nutrition, feed | — | Cited as a FY2025 profit contributor (Dealsite, 29 Jan 2026) |
| NAMINO UH / NAMINO LH | Clean-label, vegan natural seasoning materials for soups, sauces, dressings, alt-meat, seasonings | Global food processors | Shown at FiE 2023 | Insight, Nov 2023 |
| GoldRella / White Chlorella | Microalgae-based plant protein powders; gluten-free, vegan-certified | Vegan cheese, protein bars, supplements | Shown at FiE 2023 / 2024 | Proprietary culture technology (company) |
Financial Narrative
Income statement
Sources:
-
Revenue, gross profit, SG&A, R&D and D&A: S&P / StockAnalysis.
-
Operating and net income: DART via Butler.works.
-
EPS: Paasa (S&P-derived).
-
FY2025 DPS of KRW 850 is confirmed (etfshopping; KRW 30.6bn board decision of 25 Feb 2026). FY2021–FY2024 DPS are derived from cash dividends paid (KRW 28.8bn in each of 2022–2024 and KRW 30.6bn in 2025) and historical yields. Treat them as indicative.
-
Diluted EPS: no dilutive instruments identified; diluted EPS is not separately verified.
Margins
Revenue CAGR FY2021–FY2025: 6.1% (derived: KRW 3,470.0bn to KRW 4,401.3bn).
Quarterly trajectory
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | Contents | Key products |
|---|---|---|
Food (식품) | Processed foods (B2C) and food B2B / food service, domestic and overseas food subsidiaries | Chungjungone jang, sauces, dressings, seasonings and HMR; Jongga kimchi; laver; low-sugar LOWTAG line; consumer allulose; food-service supply |
Materials (소재산업) | Starch and starch sugars, fermentation and bio products, specialty sweeteners | Corn starch, glucose, fructose, maltose syrup, oligosaccharides; by-products (gluten, germ, fibre); MSG; nucleotides; lysine; histidine; NAMINO natural seasonings; GoldRella and White Chlorella microalgae; Sweevero allulose |
Segment Overview — Food
| Segment | 2Q26 |
|---|---|
Food (% of revenue) | 69 |
Materials (% of revenue) | 31 |
Income Statement and Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (KRW Bn) | 3,470.0 | 4,084.1 | 4,107.5 | 4,255.1 | 4,401.3 |
Revenue growth YoY (%) | 11.5 | 17.7 | 0.6 | 3.6 | 3.4 |
Gross profit (KRW Bn) | 878.0 | 964.2 | 1,012.9 | 1,135.7 | 1,172.5 |
SG&A (KRW Bn) | 651.2 | 734.2 | 784.4 | 840.6 | 861.7 |
R&D expense (KRW Bn) | 27.7 | 34.7 | 41.2 | 46.5 | 57.0 |
Operating income, company-reported (KRW Bn) | 153.2 | 140.0 | 123.7 | 176.9 | 169.3 |
D&A (KRW Bn) | 110.2 | 127.4 | 136.9 | 146.8 | 165.9 |
EBITDA, derived OP+D&A (KRW Bn) | 263.4 | 267.4 | 260.6 | 323.7 | 335.2 |
Net income, consolidated (KRW Bn) | 144.9 | 82.2 | 68.6 | 96.7 | -303.1 |
EPS basic (KRW) | 4,001.72 | 2,306.30 | 1,862.35 | 2,642.00 | -8,447.07 |
DPS ordinary (KRW) | 800 | 800 | 800 | 850 | 850 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansMargin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross margin (%) | 25.3 | 23.6 | 24.7 | 26.7 | 26.6 |
Operating margin (%) | 4.4 | 3.4 | 3.0 | 4.2 | 3.8 |
EBITDA margin, derived (%) | 7.6 | 6.5 | 6.3 | 7.6 | 7.6 |
Net margin (%) | 4.2 | 2.0 | 1.7 | 2.3 | -6.9 |
R&D / revenue (%) | 0.80 | 0.85 | 1.00 | 1.09 | 1.29 |
Financial Analysis
| Metric | 1Q25 | 2Q25 | 3Q25 | 4Q25 | 1Q26 | 2Q26 |
|---|---|---|---|---|---|---|
Revenue (KRW Bn) | 1,130.5 | 1,076.0 | 1,145.4 | 1,049.4 | 1,109.8 | 1,165.8 |
Operating income (KRW Bn) | 57.3 | 40.8 | 50.9 | 20.3 | 57.0 | 46.5 |
Net income (KRW Bn) | 28.4 | 18.2 | 22.4 | -372.1 | 32.6 | 19.6 |
Balance Sheet
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets (KRW Bn) | 2,870.5 | 3,190.2 | 3,334.4 | 3,509.8 | 3,479.1 |
Cash and equivalents (KRW Bn) | 586.3 | 559.0 | 742.4 | 672.8 | 595.7 |
Cash + short-term investments (KRW Bn) | 607.6 | 585.9 | 760.4 | 705.0 | 653.3 |
Short-term debt incl. current LTD (KRW Bn) | 472.4 | 561.8 | 481.1 | 655.6 | 661.8 |
Long-term debt (KRW Bn) | 462.1 | 708.1 | 863.9 | 713.9 | 654.8 |
Lease liabilities (KRW Bn) | 69.8 | 73.7 | 63.2 | 108.6 | 100.4 |
Total debt incl. leases (KRW Bn) | 1,004.3 | 1,343.6 | 1,408.3 | 1,478.1 | 1,417.0 |
Net debt (KRW Bn) | 396.7 | 757.7 | 647.8 | 773.1 | 763.8 |
Total equity incl. minorities (KRW Bn) | 1,247.2 | 1,322.6 | 1,343.7 | 1,447.6 | 1,096.9 |
Goodwill + intangibles (KRW Bn) | 111.8 | 119.2 | 151.5 | 152.6 | 163.1 |
Inventory (KRW Bn) | 515.1 | 706.5 | 540.4 | 649.1 | 696.9 |
Working capital (KRW Bn) | 564.0 | 718.7 | 793.9 | 628.6 | 213.5 |
Cash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow (KRW Bn) | 58.7 | -90.9 | 374.8 | 187.7 | 188.1 |
Capex (KRW Bn) | 160.1 | 174.4 | 180.4 | 148.0 | 137.2 |
Free cash flow (KRW Bn) | -101.5 | -265.3 | 194.5 | 39.7 | 50.9 |
Dividends paid (KRW Bn) | 25.2 | 28.8 | 28.8 | 28.8 | 30.6 |
Share buybacks (KRW Bn) | 0 | 0 | 0 | 0 | 0 |
Cash acquisitions (KRW Bn) | 8.3 | -2.3 | 29.4 | 5.6 | 28.9 |
Cash interest paid (KRW Bn) | 15.2 | 30.6 | 52.2 | 58.1 | 56.3 |
Change in working capital (KRW Bn) | -188.5 | -329.1 | 95.9 | -122.1 | -138.2 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE (%) | 12.34 | 6.40 | 5.14 | 6.93 | -23.82 |
ROA, EBIT-based (%) | 3.45 | 2.95 | 2.37 | 3.23 | 2.94 |
ROIC (%) | 7.61 | 5.69 | 4.62 | 6.63 | 8.06 |
Current ratio (x) | 1.59 | 1.72 | 1.83 | 1.54 | 1.14 |
Debt / equity (x) | 0.81 | 1.02 | 1.05 | 1.02 | 1.29 |
Net debt / EBITDA (x) | 1.53 | 2.80 | 2.49 | 2.39 | 2.31 |
Interest coverage, OP / cash interest (x) | 10.1 | 4.6 | 2.4 | 3.0 | 3.0 |
Asset turnover (x) | 1.29 | 1.35 | 1.26 | 1.24 | 1.26 |
Cash conversion cycle, derived (days) | 78.8 | 94.0 | 73.4 | 83.3 | 85.4 |
Revenue by Region and Revenue by Region (%)
| Metric | FY2017 | FY2025 | 1H2026 |
|---|---|---|---|
Jongga kimchi exports (USD Mn) | 32 | 90 | 48 |
Jongga share of Korea kimchi exports (%) | 0 | 0 | 56 |
Share Price and Market Valuation
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Year-end share price, adjusted (KRW) | 20,021.67 | 19,502.96 | 19,203.50 | 17,759.76 | 20,197.98 |
Market capitalisation (KRW Bn) | 830.8 | 780.2 | 755.1 | 686.0 | 752.7 |
Enterprise value (KRW Bn) | 1,329.9 | 1,551.7 | 1,431.5 | 1,392.6 | 1,650.4 |
P/E (x) | 5.76 | 9.39 | 11.26 | 7.21 | 0 |
P/B (x) | 0.67 | 0.59 | 0.56 | 0.47 | 0.69 |
EV/EBITDA (x) | 5.13 | 5.74 | 5.50 | 4.30 | 4.99 |
EV/Sales (x) | 0.38 | 0.38 | 0.35 | 0.33 | 0.38 |
Dividend yield (%) | 4.00 | 4.10 | 4.17 | 4.79 | 4.21 |
Payout ratio (%) | 17.50 | 34.70 | 42.98 | 30.29 | 0 |
Capital Markets
| Item | Value | Source / date |
|---|---|---|
Share price | KRW 17,610 | 8 Oct 2026 (StockAnalysis / Paasa) |
1-year return | -18.28% | Paasa |
YTD return | -16.34% | Paasa |
6-month return | -15.54% | Paasa |
3-year return (from FY2023 close) | About -8.3% | Derived (19,203.50 to 17,610) |
5-year return | -25.38% | Paasa |
P/B | 0.56x | S&P, 1 Oct 2026 |
Forward P/E | About 6.3x | S&P; Stockhub 6.41x |
EV/EBITDA | 5.20x | S&P |
EV/Sales | 0.39x | S&P |
Dividend yield | About 4.7–4.8% | S&P; Butler |
Analyst consensus target | KRW 34,500 (2 brokers; about 96% upside) | Stockhub; Butler.works |
Peer Comparison
| Company | Market cap (KRW Bn) | P/B (x) | Dividend yield (%) |
|---|---|---|---|
Daesang | 610 | 0.56 | 4.8 |
CJ CheilJedang | 2,854 | 0.42 | 3.16 |
Ottogi | 1,335 | 0.62 | 2.70 |
Samyang Corp | 487 | 0.31 | 3.71 |
Credit Ratings
| Agency | Rating | Outlook | Date | Note |
|---|---|---|---|---|
Korea Investors Service (KIS) | AA- | Stable | Jan 2021 | Upgraded from A+ (Positive), resolving a split |
NICE Investors Service | AA- | Stable | By Jan 2021 | — |
Korea Ratings | AA- | Stable | Late 2020 | Upgraded to AA- |
Moody's / S&P / Fitch | None identified | — | — | — |
Bucket Details
| Bucket | Amount |
|---|---|
Short-term borrowings | 267.7 |
Current portion of long-term debt | 257.7 |
Current lease liabilities | 38.6 |
Long-term debt (more than one year) | 692.7 |
Long-term lease liabilities | 93.2 |
Analyst Conclusions
Management guidance and consensus
Management guidance: none published. Directional commitments are high-value mix, global localisation, cost efficiency and materials restructuring (Aug 2026).
Consensus: - Simply Wall St (Aug 2025) cited about 4.0% a year of revenue growth over three years.
-
Pre-cartel estimates (Hana, Jul 2025) had FY2026E OP at KRW 223.4bn and FY2027E at KRW 232.8bn. Actual FY2025 OP of KRW 169.3bn undershot the KRW 207.2bn estimate by about 18%.
-
The forward P/E of about 6.3x implies consensus net income around KRW 95–100bn (derived from market cap; indicative only).
Bull case
-
Core earnings are intact and improving. 1H26 OP of KRW 103.5bn (+6.9%) and 2Q26 revenue of +8.3% show the franchise absorbing tariffs and weak domestic demand. Annualising 1H26 implies FY2026 OP above KRW 200bn if 2H follows typical seasonality (2H25 was KRW 71.2bn; derived).
-
The fine is already expensed and possibly over-provisioned. The KRW 375.3bn provision covers the KRW 234.1bn confirmed fine, with about KRW 141bn of headroom for pending cases. Any court reduction (about 25% of KFTC cases historically) or lighter pending penalties flows back to equity.
-
Global K-food and specialty growth is underappreciated at 0.56x book. Jongga's US-led growth (exports up about 2.8x since 2017), allulose (+300% overseas in 9M25) and natural seasonings are higher-multiple businesses than the market currently prices.
Bear case
-
Regulatory tail risk is not finished. Two further KFTC cases (up to about KRW 500bn industry-wide), criminal convictions and civil damages could exceed the remaining provision. The price re-determination order may permanently compress starch-sugar profits, a cash-cow line.
-
The balance sheet is stretched. Net debt rose to about KRW 1.08tn by June 2026 before the fine is paid. Paying KRW 234.1bn in October 2026 lifts leverage further and may pressure the AA- rating or the dividend.
-
Structural margin ceiling and governance discount. Operating margin has not exceeded 4.4% in five years; SG&A is rising; lysine is normalising. A CEO under indictment and owner-controlled boards limit re-rating potential.
Catalysts and monitorables (next 12 months)
29 Oct 2026: payment of the KRW 234.1bn fine. Watch the funding method (borrowing versus instalments) and any administrative appeal filing.
Mid-Nov 2026: 3Q26 results (3Q25 was released 14 Nov 2025). Watch food margin and lysine trends.
KFTC full-commission decisions: on the bid-rigging and by-product cases.
Criminal trial progress: and verdicts for CEO Lim and the corporation.
Credit rating reviews: by KIS, NICE and Korea Ratings.
January 2027: preliminary FY2026 results. Watch for provision true-up or release.
February–March 2027: FY2026 dividend decision (maintained at KRW 850 or cut) and the March 2027 AGM. This will be the first director election under mandatory cumulative voting and enlarged separately elected audit committees.
- Allulose capacity decisions, US/EU kimchi expansion and new-market launches (Russia, Canada, Middle East, Latin America).
Analyst verdict
Daesang enters late 2026 as two companies in one set of accounts.
The operating company is a durable, if unspectacular, Korean food and ingredients franchise:
-
record revenue of KRW 4.40tn in FY2025;
-
improving 2026 operating momentum (1H26 OP +6.9%, 2Q26 revenue +8.3%);
-
a clear international growth leg in kimchi, where Jongga controls over half of Korea's exports and has local plants in California, Poland and China;
-
a promising specialty-ingredients pipeline led by allulose and natural seasonings.
On these fundamentals alone, a valuation of 0.56x book and about 5x EV/EBITDA looks undemanding for a business generating roughly KRW 330bn of EBITDA.
The legal company is a different proposition. The KFTC's record starch-sugar ruling, the indictment of the sitting CEO and the corporation, and two further pending cases make Daesang a central defendant in Korea's broadest food-cartel enforcement wave. The FY2025 provision of KRW 375.3bn appears adequate for the confirmed fine but not obviously sufficient for the full tail: pending fines, possible convictions, civil claims and a regulated reset of starch-sugar pricing. The balance sheet, with net debt near KRW 1.08tn before the October payment, has less buffer than at any point in the past five years.
The equity story over the next 12 months therefore depends less on operations than on the legal and financing path:
-
how the fine is funded;
-
whether pending KFTC cases land within the remaining provision;
-
whether ratings and the KRW 850 dividend hold.
If those resolve broadly in line with the existing provision, the discount to book should narrow and the 4–5% yield offers support while investors wait. If they do not, the downside is less about earnings than about leverage and governance credibility.
Net assessment: a deep-value, high-uncertainty situation.
All figures are from public sources cited inline.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure / notes | Prior roles |
|---|---|---|---|
Lim Jung-bae (임정배) | CEO & President (대표이사 사장), inside director | Fourth inside-director term began 26 Mar 2026 (HuffPost Korea). Indicted 23 Apr 2026 in the starch-sugar cartel case. Two arrest warrants rejected; he disputes the allegations (Medical Daily, Apr 2026). | — |
Lim Sang-min (임상민) | Vice President (부사장), inside director | Inside director since 27 Mar 2020 (appointed as executive director for strategy); re-elected 2023 (Dealsite, 24 Mar 2023). Largest shareholder of Daesang Holdings (36.7%). | VP at Daesang America; China business strategy at Hong Kong unit; domestic strategy and new business from 2018 (The Fact, 2020) |
Oh Yeon-taek (오연택) | CEO, Kimchi CIC | Also non-executive director at Daesang Holdings (HuffPost Korea) | — |
Han Jae-chun (한재춘) | Head, Materials BU | Cited Nov 2023 (Insight) | — |
Kim (surname only) | Former head, starch-sugar business division | Detained 31 Mar 2026; indicted in custody 16 Apr 2026 (Herald) | — |
Lim Chang-wook (임창욱) | Honorary Chairman; co-CEO of Daesang Holdings (with Choi Sung-soo) | Controlling-family patriarch | — |
Lim Se-ryung (임세령) | Vice Chair, Daesang Holdings | 20.41% of Holdings (Digital Times via Dealsite, 13 Jul 2026). | — |
Board & Management Changes
| Date | Event |
|---|---|
26 Mar 2026 | CEO Lim Jung-bae re-elected for a fourth term |
31 Mar 2026 | Starch-sugar division head Kim detained |
23 Apr 2026 | CEO indicted; no resignation reported in retrieved sources |
Major Shareholders
| Holder | Stake | Date / source |
|---|---|---|
Daesang Holdings and related parties | 43.72% | 31 Dec 2025, DART via etfshopping |
— of which Daesang Holdings | 39.2% | — |
— Lim Chang-wook | 1.2% | 2019 |
— Daesang Cultural Foundation | 3.8% | 2019 |
National Pension Service | 12.4% | Feb 2025 (Hanwha) |
National Pension Service | 13.44% | Mar 2025 (NPS data via Kyunghyang, Oct 2025) |
Minority shareholders (37,286 holders) | 38.01% | 31 Dec 2025 |
Foreign ownership | 17.7% | Feb 2025 (Hanwha) |
Competitive Landscape
Competitors by Segment
| Segment | Key competitors | Positioning notes |
|---|---|---|
Jang and sauces (Korea) | CJ CheilJedang (Haechandle), Sempio, Ottogi, Sajo | — |
Kimchi | CJ CheilJedang (Bibigo), Pulmuone, Dongwon F&B | Jongga holds 56% of Korean kimchi exports (1H26) |
Laver / gim | CJ CheilJedang, Dongwon F&B, specialist exporters | A named global core category for Daesang |
Packaged foods (broad) | Ottogi, Nongshim, Samyang Foods, Pulmuone | Ottogi FY2025 revenue KRW 3,674.5bn |
Starch and starch sugar (B2B Korea) | Samyang Corp, Sajo CPK, CJ CheilJedang | The four firms hold 95.7% of starch and 86.4% of starch sugar. CJ about 12% share; the other three each above 20% (Newsis, 2026). Daesang described as industry #1 (Segye). |
Allulose | Samyang Corp (Ulsan, 13,000 t/yr), Chinese producers | Korean two-player market (Herald, Nov 2025) |
Lysine and amino acids | CJ CheilJedang Bio, Meihua, Fufeng, Eppen (China), ADM | CJ Bio FY2025 revenue KRW 3,959.4bn, OP KRW 203.4bn |
MSG and nucleotides | CJ CheilJedang, Ajinomoto, Fufeng, Meihua | Global scale players dominate |
Peer Comparison FY2025
| Metric | Daesang | CJ CheilJedang (ex-CJ Logistics) | Ottogi | Samyang Corp |
|---|---|---|---|---|
Revenue (KRW Bn) | 4,401.3 | 17,754.9 | 3,674.5 | 2,562.5 |
Revenue growth YoY (%) | 3.4 | -0.6 | 3.8 | -4.1 |
Operating income (KRW Bn) | 169.3 | 861.2 | 177.3 | 111.7 |
Operating margin (%) | 3.8 | 4.9 | 4.8 | 4.4 |
Net income, consolidated (KRW Bn) | -303.1 | -417.0 | 72.1 | -302.4 |
R&D / revenue (%) | 1.29 | 0 | 0 | 0 |
